Patients with high risk factors, such as early onset of menstruation, null parity, and age >50 years, displayed low levels of CYP19A1 gene expression in tumor and peritumoral tissue (10), unlike the findings of Clemons and Goss (48). The gene discussed is CYP19A1; the disease is neoplasm.